Jenot W. and William U. Shipley Professor of Radiation Oncology, Massachusetts General Hospital
Radiation Oncology
Dr. Anthony L. Zietman, MD
|
|
Give Review
Anthony Zietman practices Radiation Oncology. He over the years received 4 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer" and "Super Doctor". Anthony Zietman is a published doctor. He published 100 publications, including: 'A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.' Dr. Anthony L. Zietman accepts all Medicare patients.
Publications
- Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.
- Taking "the Game" Out of The Match: A Simple Proposal.
- A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
- Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.
- Androgen deprivation with radiotherapy: how long is long enough?
- Clinical trial registration: a mandatory requirement for publication in the red journal.
- Active surveillance for prostate cancer: the role of the pathologist.
- Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy...
- Introducing prospective manuscript review to address publication bias.
- Too much impact? Scientific journals and the "impact factor".
- The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement wi...
- Promise and Pitfalls of Heavy-Particle Therapy.
- Attitudes toward blinding of peer review and perceptions of efficacy within a small biomedical specialty.
- Bringing radiation therapy to underserved nations: an increasingly global responsibility in an ever-shrinking world.
- Complications of prostate cancer treatment.
- In reply to bauman.
- Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base.
- Outcomes in a Multi-institutional Cohort of Patients Treated With Intraoperative Radiation Therapy for Advanced or Recurrent Renal Cell Carcinoma.
- Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer.
- Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society f...
- Falsification, fabrication, and plagiarism: the unholy trinity of scientific writing.
- Using Patient-Reported Outcomes to Assess and Improve Prostate Cancer Brachytherapy.
- Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancer.
- Trimodality bladder preservation therapy for muscle-invasive bladder cancer.
- Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder.
- Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for p...
- The Red Journal's Most Downloaded Articles of 2012.
- Practice-Based Evidence to Evidence-Based Practice: Building the National Radiation Oncology Registry.
- Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated ...
- Clinical controversies: proton therapy for prostate cancer.
- Evaluation of Adherence to Quality Measures for Prostate Cancer Radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) Survey.
- Proton beam therapy and accountable care: the challenges ahead.
- Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning.
- Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
- Proton beam therapy and localised prostate cancer: current status and controversies.
- Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.
- Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields.
- The Red Journal's Outstanding Reviewer Awards for 2012.
- Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer.
- Prostate specific antigen best practice statement: 2009 update.
- Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
- Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Out...
- Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer.
- Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy.
- Adjuvant radiation therapy for early stage seminoma: Proton versus photon planning comparison and modeling of second cancer risk.
- Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level.
- Receiving the torch.
- Reply from Authors re: Giuseppe Simone, Michele Gallucci. Multimodality Treatment Versus Radical Cystectomy: Bladder Sparing at Cost of Life? Eur Urol. In press. DOI:1...
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience.
- Long-Term Quality of Life Outcome after Proton Beam Monotherapy for Localized Prostate Cancer.
- Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
- Comparison of High-Dose Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis.
- Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.
- Survivin is a potential mediator of prostate cancer metastasis.
- Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for ...
- Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.
- Acute and Late Toxicity After Dose Escalation to 82 GyE Using Conformal Proton Radiation for Localized Prostate Cancer: Initial Report of American College of Radiology...
- Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer.
- American society for radiation oncology intersociety summit summary.
- Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton ra...
- Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
- Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation th...
- Life, liberty, and the pursuit of protons: an evidence-based review of the role of particle therapy in the treatment of prostate cancer.
- Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
- Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy fol...
- Why does androgen deprivation enhance the results of radiation therapy?
- Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
- Management of complications of prostate cancer treatment.
- Proton-beam vs intensity-modulated radiation therapy. Which is best for treating prostate cancer?
- Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
- Correction: Inaccurate analysis and results in a study of radiation therapy in adenocarcinoma of the prostate.
- External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
- Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
- Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
- High-dose external beam radiation for localized prostate cancer: current status and future challenges.
- The Titanic and the Iceberg: prostate proton therapy and health care economics.
- Case records of the Massachusetts General Hospital. Case 18-2007. A 54-year-old man with early-stage prostate cancer.
- Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
- Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.
- Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
- Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.
- Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy a...
- Comparison of biochemical failure definitions for permanent prostate brachytherapy.
- Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.
- PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
- Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony ana...
- Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.
- Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
- PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failure.
- Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutiona...
- Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts...
- Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2004. A 63-year-old man with metastatic prostate carcinoma refractory...
- Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition.
- Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.
- RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adju...
- Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis.
- Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term su...
- Case records of the Massachusetts General Medicine. Weekly clinicopathological exercises. Case 9-2003. An 18-year-old man with back and leg pain and a nondiagnostic bi...
Schools
University Of London Faculty Of Med
University Of London
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Super Doctor
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1811972904 | |
| NPPES Provider LastName | ZIETMAN | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 021142617 | |
| NPPES Provider State | MA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 113.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811972904 |
| Last Name Of The Provider | ZIETMAN |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Sophia C. Kamran, MD |
|
|
Dr. Kristina L. Mirabeau-Beale, MD |
|
|
Dr. Florence K. Keane, MD |
|
|
Dr. Christine E. Eyler, MD |
|
|
Dr. Ann C. Raldow, MD |
|
|
Dr. Sean M. McBride, MD |
|
|
Dr. Raymond H. Mak, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart M. Berman, MD |
|
|
Dr. Ellen M. Kornmehl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary A. Stevenson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Olsen, MD |
|
|
Dr. Margarita Racsa Alamgir, MD |
|
|
Dr. Yen-Lin E. Chen, MD |
|
|
Dr. Elena A. Nedea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen J. Marcus, MD
This Doctor is OpenDoctor Recommended.
|